Laurion Capital Management LP Cytom X Therapeutics, Inc. Call Options Transaction History
Laurion Capital Management LP
- $5.23 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CTMX
# of Institutions
70Shares Held
42.9MCall Options Held
3KPut Options Held
8.3K-
Tang Capital Management LLC San Diego, CA7.31MShares$5.85 Million0.57% of portfolio
-
Bvf Inc San Francisco, CA5.23MShares$4.18 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.16MShares$4.13 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX3.91MShares$3.12 Million1.19% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.22MShares$2.58 Million0.0% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $52.8M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...